Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $2.0 million.

  • Jaguar Health's Cost of Revenue fell 64.68% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 4861.71%. This contributed to the annual value of $7.7 million for FY2024, which is 1907.12% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Cost of Revenue is $2.0 million, which was down 64.68% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Cost of Revenue registered a high of $2.8 million during Q1 2022, and its lowest value of $1.4 million during Q1 2024.
  • Its 5-year average for Cost of Revenue is $2.0 million, with a median of $2.1 million in 2022.
  • As far as peak fluctuations go, Jaguar Health's Cost of Revenue tumbled by 3354.5% in 2023, and later skyrocketed by 7733.51% in 2024.
  • Quarter analysis of 5 years shows Jaguar Health's Cost of Revenue stood at $2.3 million in 2021, then fell by 23.93% to $1.7 million in 2022, then fell by 12.41% to $1.5 million in 2023, then surged by 77.34% to $2.7 million in 2024, then dropped by 26.45% to $2.0 million in 2025.
  • Its Cost of Revenue was $2.0 million in Q3 2025, compared to $2.5 million in Q2 2025 and $2.5 million in Q1 2025.